Biologics & Biosimilars: A Discussion & Educational Opportunity for Physicians, Advocates & Opinion Leaders-Wednesday
The Patient Protection and Affordable Care Act (PPACA) adopted several important changes to the delivery of healthcare since its enactment in 2010. One of the least understood provisions is that of an approval pathway for biosimilar products. Georgia Bio and the ACTSI invite you to an expert panel presentation and roundtable discussion of the science of biologics and biosimilars, the newly approved regulatory pathway and how potential changes to the legislation could impact physicians and patients in Georgia.